Page last updated: 2024-12-09
2-azabicyclo(2.2.1)hept-5-en-3-one
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2-azabicyclo(2.2.1)hept-5-en-3-one: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 548678 |
| SCHEMBL ID | 548616 |
| MeSH ID | M0172621 |
Synonyms (43)
| Synonym |
|---|
| 3-azabicyclo[2.2.1]hept-5-en-2-one |
| 49805-30-3 |
| A1359 |
| 2-azabicyclo[2.2.1]hept-5-en-3-one |
| EN300-82926 |
| (-)-2-azabicyclo[2.2.1]hept-5-en-3-one |
| A827858 |
| AKOS006223009 |
| 2-azabicyclo(2.2.1)hept-5-en-3-one |
| FT-0643143 |
| FT-0600312 |
| FT-0601151 |
| (-)-(1r,4s)-2-azabicyclo[2.2.1]hept-5-en-3-one |
| SCHEMBL548616 |
| 2-azabicyclo[2.2.1]hept-5-en-3-one # |
| 2-azabicyclo[2.2.1]hept-5-en-3-one, (1s)- |
| J-500009 |
| (-)-2-azabicyclo[2,2,1]hept-5-en-3-one |
| (+/-)-2-azabicyclo [2.2.1]hept-5-en-3-one |
| (+/-)-2-azabicyclo[2.2.1 ]hept-5-en-3-one |
| (-)-2-azabicyclo [2.2.1]hept-5-en-3-one |
| (-)-2-azabicyclo [2.2.1] hept-5-en-3one |
| racemic 2-aza bicyclo[2.2.1]hept-5-ene-3-one |
| J-650015 |
| (1r)-(-)-2-azabicyclo[2,2,1]hept-5-en-3-one |
| Q-200006 |
| J-650014 |
| J-650392 |
| azabicyclo[2.2.1]hept-5-en-3-one |
| rac 2-azabicyclo[2.2.1]hept-5-en-3-one |
| (r,s)-2-azabicyclo(2.2.1)hept-5-en-3-one |
| ec 421-830-3 |
| AC-6114 |
| 3-oxo-2-azabicyclo[2.2.1]hept-5-ene |
| SY004961 |
| CS-W019811 |
| DTXSID40868505 |
| 61865-48-3 |
| SY096758 |
| DS-11069 |
| SB18483 |
| SB18484 |
| SB11075 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 20.14
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (20.14) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (14.29%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (85.71%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||